Are there any programs available to help cover the cost of lurbinectedin?

Copay Assistance for Lurbinectedin

Lurbinectedin (Zepzelca), used for metastatic small cell lung cancer, has high costs—often $15,000+ per dose. Jazz Pharmaceuticals offers the Zepzelca Copay Assistance Program, which covers copays, coinsurance, or deductibles up to $25,000 per year for commercially insured patients. Eligibility requires U.S. residency, valid prescription, and no government insurance like Medicare/Medicaid. Apply via ZepzelcaAccess.com or call 1-833-4ZEPZEL (1-833-493-7935).[1][2]

Free Drug Programs

The Zepzelca Patient Assistance Program provides free medication to uninsured or underinsured patients meeting income guidelines (typically ≤400-500% of federal poverty level). No copay required; approval can take days to weeks. Contact Jazz Cares at 1-800-255-5163 or apply online.[1][3]

How to Qualify and Apply

Programs prioritize financial need via income proof (tax returns, pay stubs). Commercial patients use copay cards instantly at pharmacies; others get shipped drugs. Reapply annually. Independent foundations like Patient Access Network (PAN) or CancerCare may bridge gaps if ineligible—PAN covers up to $10,800 yearly for lung cancer drugs.[4][5]

Alternatives if Ineligible

• Manufacturer Bridge Programs: Temporary free supply during insurance delays.
  
• Specialty Pharmacies: ZepzelcaAccess coordinates prior authorizations.
  
• State Programs: Varies by location; check for cancer drug assistance.
  No generic or biosimilar exists yet—patent protection lasts until at least 2031 per DrugPatentWatch.com.6
  
  [1]: https://zepzelcaaccess.com/
  [2]: https://www.zepzelca.com/support-and-resources
  [3]: https://jazzcares.com/zepzelca
  [4]: https://panfoundation.org/
  [5]: https://www.cancercare.org/